| PERIOD ENDING | 2-Aug-09 | 3-May-09 | 1-Feb-09 | 2-Nov-08 | | Total Revenue | 95,401 | 83,233 | 88,042 | 103,306 | | Cost of Revenue | 77,347 | 71,792 | 77,483 | 85,354 | | | Gross Profit | 18,054 | 11,441 | 10,559 | 17,952 | | | Operating Expenses | | Research Development | 3,854 | 4,177 | 3,624 | 4,327 | | Selling General and Administrative | 9,963 | 10,630 | 10,402 | 11,547 | | Non Recurring | 10,660 | 1,864 | 1,680 | 510 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (6,423) | (5,230) | (5,147) | 1,568 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (8,869) | (572) | 1,023 | 3,624 | | Earnings Before Interest And Taxes | (15,292) | (5,802) | (4,124) | 5,192 | | Interest Expense | 5,351 | 4,430 | 4,646 | 3,600 | | Income Before Tax | (20,643) | (10,232) | (8,770) | 1,592 | | Income Tax Expense | 1,805 | (75) | 1,197 | 1,438 | | Minority Interest | (399) | 85 | (266) | 82 | | | | Net Income From Continuing Ops | (22,847) | (10,072) | (10,233) | 236 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (22,847) | (10,072) | (10,233) | 236 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($22,847) | ($10,072) | ($10,233) | $236 |
|
0.31% Nasdaq 
0.05%
Income Statement
